• 2084 Citations
  • 26 h-Index
20002020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Seok-Gu Kang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 2084 Citations
  • 26 h-Index
  • 119 Article
  • 3 Conference contribution
  • 3 Review article
  • 1 Letter

A Mechanism for microRNA Arm Switching Regulated by Uridylation

Kim, H., Kim, J., Yu, S., Lee, Y. Y., Park, J., Choi, R. J., Yoon, S. J., Kang, S. G. & Kim, V. N., 2020 Jun 18, In : Molecular Cell. 78, 6, p. 1224-1236.e5

Research output: Contribution to journalArticle

  • 1 Citation (Scopus)

    Association between survival and levetiracetam use in glioblastoma patients treated with temozolomide chemoradiotherapy

    Roh, T. H., Moon, J. H., Park, H. H., Kim, E. H., Hong, C. K., Kim, S. H., Kang, S. G. & Chang, J. H., 2020 Dec 1, In : Scientific reports. 10, 1, 10783.

    Research output: Contribution to journalArticle

    Open Access
  • ATM mutations improve radio-sensitivity in wild-type isocitrate dehydrogenase-associated high-grade glioma: retrospective analysis using next-generation sequencing data

    Kim, N., Kim, S. H., Kang, S. G., Moon, J. H., Cho, J., Suh, C. O., In Yoon, H. & Chang, J. H., 2020 Jul 31, In : Radiation oncology (London, England). 15, 1, p. 184 1 p.

    Research output: Contribution to journalArticle

    Open Access
  • Combined effects of niclosamide and temozolomide against human glioblastoma tumorspheres

    Oh, H. C., Shim, J. K., Park, J., Lee, J. H., Choi, R. J., Kim, N. H., Kim, H. S., Moon, J. H., Kim, E. H., Chang, J. H., Yook, J. I. & Kang, S. G., 2020, (Accepted/In press) In : Journal of cancer research and clinical oncology.

    Research output: Contribution to journalArticle

    Open Access
  • Concurrent and Adjuvant Temozolomide for Newly Diagnosed Grade III Gliomas without 1p/19q Co-deletion: A Randomized, Open-Label, Phase 2 Study (KNOG-1101 Study)

    Hwang, K., Kim, T. M., Park, C. K., Chang, J. H., Jung, T. Y., Kim, J. H., Nam, D. H., Kim, S. H., Yoo, H., Hong, Y. K., Kim, E. Y., Lee, D. E., Joo, J., Kim, Y. J., Choe, G., Choi, B. S., Kang, S. G., Kim, J. H. & Kim, C. Y., 2020 Apr 1, In : Cancer research and treatment : official journal of Korean Cancer Association. 52, 2, p. 505-515 11 p.

    Research output: Contribution to journalArticle

    Open Access
  • Press / Media

    A Breakthrough for Understanding Glioblastoma: Origin Cell...

    Seok-Gu Kang

    18/8/9

    1 item of Media coverage

    Press/Media: Press / Media

    Origin Cells for Deadly Brain Tumors Identified

    Seok-Gu Kang

    18/8/6

    1 item of Media coverage

    Press/Media: Press / Media

    Origin cells for deadly brain tumours identified

    Seok-Gu Kang

    18/8/3

    1 item of Media coverage

    Press/Media: Press / Media